CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–EQRx, Inc., a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, and CM Life Sciences III, Inc. (NASDAQ: CMLTU), a life science-focused…

Click here to view the original article.